United Therapeutics (UTHR) Asset Utilization Ratio (2010 - 2026)

United Therapeutics has disclosed Asset Utilization Ratio across 17 years of filings, most recently posting 0.43 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.43, up 9.59% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.43 (up 9.59% YoY), and the FY2025 annual result was 0.42, up 5.44% from the prior year.
• Asset Utilization Ratio came in at 0.43 for Q1 2026 at United Therapeutics, up from 0.42 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.43 in Q1 2026 to a low of 0.32 in Q1 2023.
• The 5-year median for Asset Utilization Ratio is 0.37 (2024), against an average of 0.37.
• Across the five-year window, Asset Utilization Ratio retreated 4.79% in 2023 and rose 23.76% in 2024, its largest moves.
• United Therapeutics' Asset Utilization Ratio stood at 0.33 in 2022, then rose by 0.17% to 0.33 in 2023, then gained by 21.1% to 0.4 in 2024, then rose by 5.21% to 0.42 in 2025, then advanced by 3.94% to 0.43 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.43 (Q1 2026), 0.42 (Q4 2025), and 0.41 (Q3 2025), per Business Quant data.